Skip to main content

Table 1 Patient characteristics. (1) Long-term use group

From: A laboratory data-based evaluation of the efficacy and safety of generic pravastatin sodium for long-term use

 

Long-term continued use

Discontinuation (long-term)

Patients (N)

556

39

Men/women (N)

224/332

18/21

Mean age (years)

68.8 ± 10.9

73.8 ± 11.8

Mean treatment duration (weeks)

177 ± 3.61

158 ± 3.54